Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This study will determine the effectiveness of artemisinin plus risperidone in improving
symptoms and cognitive disturbances and in Chinese people with schizophrenia. The study
addresses the Toxoplasma infection hypothesis of schizophrenia.